Alert: Rating Downgrade (10/1/24)-Adverum Biotechnologies Inc (NASDAQ: ADVM).
Stock Rating Downgrade During the last several trading days the Value Trend Rating for Adverum Biotechnologies Inc (NASDAQ: ADVM) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Adverum […]